It is intriguing and worthwhile to further investigate this mechanism in future studies including the interaction between HER2-positive cells and HER2-negative cells, as well as that of cancer cells and stromal cells to definitively elucidate the mechanism underlying the possible association between HER2 heterogeneity and the malignant potential of HER2-positive breast cancer. Here, ERBB2 is linked to breast carcinoma.